Ultra‐Deep Pyrosequencing of Hepatitis B Virus Quasispecies from Nucleoside and Nucleotide Reverse‐Transcriptase Inhibitor (NRTI)–Treated Patients and NRTI‐Naive Patients
Open Access
- 1 May 2009
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 199 (9) , 1275-1285
- https://doi.org/10.1086/597808
Abstract
The dynamics of emerging nucleoside and nucleotide reverse-transcriptase inhibitor (NRTI) resistance in hepatitis B virus (HBV) are not well understoKeywords
This publication has 39 references indexed in Scilit:
- Antiviral Resistance Mutations Potentiate hepatitis B virus Immune Evasion through Disruption of its Surface Antigen a DeterminantAntiviral Therapy, 2008
- Antiviral drug-resistant HBVHepatology, 2007
- Dual effect of APOBEC3G on Hepatitis B virusJournal of General Virology, 2007
- Sensitive Line Probe Assay That Simultaneously Detects Mutations Conveying Resistance to Lamivudine and AdefovirJournal of Clinical Microbiology, 2006
- Role and Mechanism of Action of the APOBEC3 Family of Antiretroviral Resistance FactorsJournal of Virology, 2006
- HBV drug resistance: Mechanisms, detection and interpretationJournal of Hepatology, 2006
- Characteristics of Hepatitis B Virus Isolates of Genotype G and Their Phylogenetic Differences from the Other Six Genotypes (A through F)Journal of Virology, 2002
- A new genotype of hepatitis B virus: complete genome and phylogenetic relatednessMicrobiology, 2000
- Naturally Occurring Variants of Hepatitis B VirusPublished by Elsevier ,1999
- Amplimers with 3'-terminal phosphorothioate linkages resist degradation by vent polymerase and reduce Taq polymerase mispriming.Genome Research, 1992